Panitumimab in combination with radiotherapy in patients with locally advanced KRAS wildtype rectal cancer (clinical stages II and III)
Read time: 1 mins
Last updated:11th Jun 2010
The primary objective of the study is to estimate the efficacy of panitumumab concurrent to radiotherapy in patients with wild-type KRAS. The rate of pathological complete remissions will be compared to expectations derived from historical data.
|Study start date||2010-06-11|